HAVCR2 and colorectal cancer: CTLA-4, TIM-3, and LAG-3 are mainly co-expressed on FoxP3+Helios+Tregs in the TME, suggesting that Tregs may hinder the response of colorectal cancer patients to IC blockade (35).